Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 530 |
---|---|
Genomic Coordinate (GRCh38) | g.22212930C>G |
Variant | c.1672C>G |
Variant Start Position | 1672 |
Location | Exon 16 |
Amino Acid Change | p.Pro558Ala |
ACMG Call | - |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Likely Pathogenic | Effect Type | Missense |
Variant Type | SNV |
PMID | 18046499, 23813354, 21293852, 24857004, 34806794 |
Article Count | 5 |
Times Observed | 3-5 |
Clinical Phenotype | - |
ACMG Categories | pm2, pp1, pp3 |
ACMG Explanations | pm2: chrX:22231047 ref:C alt:G was not found in gnomAD exomes or genomes. pp3: The SIFT, MutationTaster, and PolyPhen predictions agree that this variant is possibly or probably damaging. |
Variant in Clinvar | No |
ClinVar Classification | - |
Categories In Literature | pp1 |
No Contrary Evidence Found | Yes |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | No |
Literature Alleles | - |
GnomAD Alleles | - |
DBNSFP Alleles | X-22231047-C-G |
Other Alleles | X-22231047-CCT-GCG X-22231047-CCT-GCC X-22231047-CCT-GCA |
Note | nan |
Warnings | - |